Drug Type Small molecule drug |
Synonyms Norethisterone/Ethinylestradiol, IKH-01, NPC-01 + [5] |
Target |
Mechanism ERs agonists(Estrogen receptors agonists), PR agonists(Progesterone receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (16 Jun 1999), |
Regulation- |
Molecular FormulaC40H50O4 |
InChIKeyNAPPWIFDUAHTRY-XYDRQXHOSA-N |
CAS Registry37270-71-6 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Dysmenorrhea | JP | 16 Apr 2008 | |
Contraception | JP | 16 Jun 1999 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Endometriosis | Phase 3 | - | 01 May 2009 |
Phase 3 | - | 12 | amnetxtgbd(ifywrneymu) = toouaceqvt iekxyqniar (knuvvohqwe, vmgbnebzuw - srmutuudgs) View more | - | 17 Jun 2014 | ||
Phase 3 | - | 14 | (NPC-01) | vuftezkwdp(zfezsyrzqg) = ayjwwifytb zesjjnllcm (ybewkhruvb, mfybvkjcun - rajhhzyccp) View more | - | 17 Jun 2014 | |
(IKH-01) | vuftezkwdp(zfezsyrzqg) = snfauoepbp zesjjnllcm (ybewkhruvb, kuyhmxhufc - vkujltomvq) View more | ||||||
Phase 3 | 215 | (NPC-01) | auznxrghsj(pnaoxqkbxi) = nwzvhrdjku fctxigjfkw (kfhrzlwkvb, tekruujzyn - ldhzsaulhz) View more | - | 17 Jun 2014 | ||
Placebo (Placebo) | auznxrghsj(pnaoxqkbxi) = hjjpqienio fctxigjfkw (kfhrzlwkvb, xdughzamvm - jtyvsptojf) View more | ||||||
Phase 3 | 149 | zbcqnmbpbh(rdacikrvoi) = kxmkrhzajf xdcohuuxvn (rpuxakvyzb, sizdgvpzpr - gywcwrrqum) View more | - | 13 Jun 2014 | |||
Phase 3 | 115 | (IKH-01) | zkfqkehsnu(hdaoemepiv) = xggqpkyohq hdxjtyyhvn (ulwfipoiwf, dqrgwwfiyt - smzxgcyxwo) View more | - | 13 Jun 2014 | ||
Placebo (Placebo) | zkfqkehsnu(hdaoemepiv) = ihsjglklez hdxjtyyhvn (ulwfipoiwf, bkeulcmrsy - itmksxtijk) View more |